In depth 

Finding the cure: autoimmune illnesses

Finding the cure: autoimmune illnesses

If pharmaceutical drugs are big business, Humira is the biggest of them all. For five years, it has headed the roster of the world’s top-selling medicines, generating almost $90bn (£63bn) for its owner, AbbVie (US:ABBV), since it was launched in 2011.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now